tiprankstipranks
Trending News
More News >
Ondine Biomedical, Inc. (GB:OBI)
LSE:OBI
UK Market

Ondine Biomedical, Inc. (OBI) Income Statement

Compare
12 Followers

Ondine Biomedical, Inc. Income Statement

Last quarter (Q4 2024), Ondine Biomedical, Inc.'s total revenue was C$667.53K, an increase of 68.68% from the same quarter last year. In Q4, Ondine Biomedical, Inc.'s net income was C$-6.36M. See Ondine Biomedical, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
C$ 2.05MC$ 1.20MC$ 638.00KC$ 2.57MC$ 1.79M
Gross Profit
C$ 1.32MC$ 703.00KC$ 287.00KC$ 1.25MC$ 649.00K
Operating Expenses
C$ 20.77MC$ 15.51MC$ 19.05MC$ 18.77MC$ 16.52M
Depreciation and Amortization
C$ 565.00KC$ 587.00KC$ 493.00KC$ 514.00KC$ 1.22M
EBITDA
C$ -18.49MC$ -13.79MC$ -18.85MC$ -48.36MC$ -14.56M
Operating Income
C$ -19.44MC$ -14.80MC$ -18.76MC$ -17.52MC$ -15.87M
Other Income/Expenses
C$ 346.00KC$ 393.00KC$ -609.00KC$ -32.56MC$ -400.00K
Pretax Income
C$ -19.10MC$ -14.41MC$ -19.37MC$ -50.09MC$ -16.21M
Net Income
C$ -19.10MC$ -14.41MC$ -19.37MC$ -50.09MC$ -16.27M
Per Share Metrics
Basic EPS
C$ -0.07C$ -0.07C$ -0.10C$ -0.26C$ -0.08
Diluted EPS
C$ -0.07C$ -0.07C$ -0.10C$ -0.26C$ -0.08
Weighted Average Shares Outstanding
274.60M 197.11M 194.59M 194.59M 194.59M
Weighted Average Shares Outstanding (Diluted)
274.60M 197.11M 194.59M 194.59M 194.59M
Currency in CAD

Ondine Biomedical, Inc. Earnings and Revenue History